Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Non-cash Items: 2019-2024

Historic Non-cash Items for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $5.9 million.

  • Beam Therapeutics' Non-cash Items rose 14.97% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 14.97%. This contributed to the annual value of $5.9 million for FY2024, which is 22.38% up from last year.
  • As of FY2024, Beam Therapeutics' Non-cash Items stood at $5.9 million, which was up 22.38% from $4.8 million recorded in FY2023.
  • Beam Therapeutics' Non-cash Items' 5-year high stood at $300.6 million during FY2021, with a 5-year trough of $1.4 million in FY2020.
  • In the last 3 years, Beam Therapeutics' Non-cash Items had a median value of $4.8 million in 2023 and averaged $4.8 million.
  • Per our database at Business Quant, Beam Therapeutics' Non-cash Items spiked by 20,880.74% in 2021 and then plummeted by 98.74% in 2022.
  • Over the past 5 years, Beam Therapeutics' Non-cash Items (Yearly) stood at $1.4 million in 2020, then skyrocketed by 20,880.74% to $300.6 million in 2021, then plummeted by 98.74% to $3.8 million in 2022, then climbed by 27.12% to $4.8 million in 2023, then increased by 22.38% to $5.9 million in 2024.